AD-Omics is supporting the newly announced UK Pre-clinical Translational Models Hub as a technical partner.
Published
Signal category
Partnerships
Quote
“Singleron is supporting the newly announced UK Pre-clinical Translational Models Hub as a technical partner.”
— Nan Fang|AD-Omics team
Company
AD-Omics
Single Cell Multi-Omics for a Healthy Future
- Industry
- Biotechnology Research
- Company size
- 8 employees
AD-Omics brings together Singleron Biotechnologies, an innovator in single-cell and multi-omics technologies, and the Institute for Healthier Living Abu Dhabi (IHLAD), a research institution dedicated to advancing community health, preventive medicine and longevity in the UAE and beyond. Singleron provides integrated solutions for single-cell and multi-omics research, including automated tissue dissociation systems, high-throughput single-cell processing platforms, reagent kits and library preparation sets, advanced bioinformatics software and end-to-end service options that support sample-to-publication workflows. IHLAD provides precise, predictive, preventive, and data-driven care and research focused on lifestyle, longevity, and performance. Its mission is to shift healthcare from reactive treatment toward proactive, personalized, and population-level health optimization, supported by artificial intelligence and translational science. By uniting molecular innovation with precision lifestyle medicine, AD-Omics accelerates discoveries that advance personalized, data-driven, and preventive healthcare across the Middle East.